Manufacturer: Cipla http://www.cipla.com/
IndicationTadacip is indicated for the treatment of erectile dysfunction in men.
CompositionTadacip 20Each film-coated tablet contains Tadacip 20mg
UseUnder normal circumstances, when a man is sexually stimulated, the penis fills up with blood. When erectile dysfunction occurs, enough blood does not flow to cause an erection. TADACIP, with Cipla, relaxes the penile blood vessels when a man is sexually stimulated. This allows blood flow into the penis, resulting in an erection. The erection subsides after sex, just as it is supposed to in normal conditions. Please understand that TADACIP is not a hormone or aphrodisiac, it works only when a man is sexually stimulated.
Dosage and Administration
Use in adult men:The recommended dose is 10 mg taken prior to anticipated sexual activity and without regard to food. In those patients in whom TADACIP 10 mg does not produce an adequate effect, 20 mg might be tried. Cipla may improve erectile function up to 36 hours following dosing. Therefore, when advising patients on optimal use of TADACIP, this should be taken into consideration. The maximum recommended dosing frequency is once per day. Daily use of the medication is strongly discouraged because the long-term safety after prolonged daily dosing has not been established.
Use in elderly men:Dosage adjustments are not required in elderly patients.
Use in men with impaired renal function:No dose adjustment is required in patients with mild renal insufficiency. For patients with moderate (creatinine clearance 31 to 50 mL/min) renal insufficiency, a starting dose of 5 mg not more than once daily is recommended, and the maximum dose should be limited to 10 mg not more than once in every 48 hours. For patients with severe (creatinine clearance <30 mL/min) renal insufficiency on hemodialysis, the maximum recommended dose is 5 mg.
Use in men with impaired hepatic function:For patients with mild or moderate degrees of hepatic impairment, the dose of TADACIP should not exceed 10 mg once daily. In patients with severe hepatic impairment, the use of TADACIP is not recommended.
Use in men with diabetes:Dosage adjustments are not required in diabetic patients.
Use in children and adolescents:
TADACIP should not be used in individuals below 18 years of age.